All AbMole products are for research use only, cannot be used for human consumption.
For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.
Trifluoperazine is an FDA-approved antipsychotic drug for schizophrenia. It is an inhibitor of calmodulin (CaM) and Dopamine D2 receptor with an IC50 value of 1.2 nM for D2 receptor.
| Molecular Weight | 407.5 |
| Formula | C21H24F3N3S |
| CAS Number | 117-89-5 |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[1] Luana E Piccini, et al. Arch Virol. Inhibition of dengue virus infection by trifluoperazine
[4] Kai Koch, et al. Cochrane Database Syst Rev. Trifluoperazine versus placebo for schizophrenia
[5] L O Marques, et al. Cochrane Database Syst Rev. Trifluoperazine for schizophrenia
| Related Dopamine Receptor Products |
|---|
| AJ-76
AJ-76 ((+)-AJ 76; (1S,2R)-AJ 76) is a dopamine autoreceptor antagonist. |
| A-412997
A-412997 is a selective Dopamine D4 agonist with Ki values of 12 and 7.9 nM for the rat and human receptors. |
| SKF 81297
SKF 81297 is a potent and selective dopamine D1 receptor agonist. |
| GBR 12783
GBR 12783 is a specific, potent and selective dopamine uptake inhibitor that inhibits the [3H]dopamine uptake by rat and mice striatal synaptosomes with IC50s of 1.8 nM and 1.2 nM, respectively. |
| RMI-61140
RMI-61140 is an orally active neuroleptics. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
